Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results

Gross Margin Improved 300 basis points to 31% Year-Over-Year

Adjusted EBITDA Grew 30% Year-Over-Year

EPS Grew 45% Year-Over-Year

TAMPA, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today reported its financial results for the fourth quarter and year ended December 31, 2023.

Kent Cunningham, CEO of Better Choice, stated, “In 2023, we realized significant gross margin improvement to 31%, fueled by strategic pricing initiatives and a 3% YOY improvement of input costs - a reflection of operational discipline and unlocking profit through high production supply volumes. Our further continued focus on financial discipline and a path to profitability is reflected in the 29% adjusted EBITDA growth and significant improvement in cash burn during the year. The topline decline was a primary result of normalizing stock levels in our International markets, purposefully exiting unprofitable accounts, and attrition related to the late 2022 migration of the former TruDog brand to the Halo brand umbrella in our digital channels. Significant strategic shifts were purposefully made across channels to ensure recoverability and long-term viability of the Halo brand. Our 2024 annual operating plan includes a strategic pivot in our digital and marketing investment allocation strategies to drive brand growth and discoverability. Looking forward, we are focused on accelerating topline momentum, keeping product quality at the forefront, and continuous improvement initiatives to fuel our future growth trajectory. We closed the year with a solid footing to build upon brand equity and enhanced profitability further in 2024.”


  • Operating loss improved 47% YOY to $(12.7) million
  • Operating margin improved 3,800 basis points (“bps”) YOY to (-223%)
  • Net loss improved 40% YOY to $(14.7) million
  • Earnings (loss) per share (“EPS”) improved 40% YOY to ($20.84)
  • Adjusted EBITDA improved 30% YOY to $(3.4) million1


  • Gross margin improved 300 bps YOY to 31%
  • Operating loss improved 45% YOY to $(21.2) million
  • Operating margin improved 1,600 bps YOY to (-55%)
  • Net loss improved 42% YOY to $(22.8) million
  • EPS improved 45% YOY to ($32.29)
  • Adjusted EBITDA improved 32% YOY to $(8.0) million1
Better Choice Company Inc.
Unaudited Condensed Consolidated Statements of Operations
(Dollars in thousands, except share and per share amounts)
  Year Ended December 31,
  2023   2022
Net sales $ 38,592     $ 54,660  
Cost of goods sold   26,795       39,399  
Gross profit   11,797       15,261  
Operating expenses:      
Selling, general and administrative   24,444       35,430  
Impairment of goodwill         18,614  
Impairment of intangible assets   8,532      
Total operating expenses   32,976       54,044  
Loss from operations   (21,179 )     (38,783 )
Other expenses:      
Interest expense, net   (1,353 )     (551 )
Change in fair value of warrant liability   (236 )      
Total other expense, net   (1,589 )     (551 )
Net loss before income taxes   (22,768 )     (39,334 )
Income tax expense (benefit)   2       (18 )
Net loss available to common stockholders $ (27,770 )   $ (39,316 )
Weighted average number of shares outstanding, basic   705,185       667,114  
Weighted average number of shares outstanding, diluted   705,185       667,114  
Net loss per share available to common stockholders, basic $ (32.29 )   $ (58.93 )
Net loss per share available to common stockholders, diluted $ (32.29 )   $ (58.93 )
All share and per share amounts related to the Company's common stock for all periods presented herein have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split.

Better Choice Company Inc.
Unaudited Condensed Consolidated Balance Sheets
(Dollars in thousands, except share and per share amounts)
  December 31, 2023   December 31, 2022
Cash and cash equivalents $ 4,455     $ 3,173  
Restricted cash         6,300  
Accounts receivable, net   4,354       6,744  
Inventories, net   6,611       10,257  
Prepaid expenses and other current assets   812       1,051  
Total Current Assets   16,232       27,525  
Fixed assets, net   230       375  
Right-of-use assets, operating leases   120       173  
Intangible assets, net         10,059  
Other assets   155       544  
Total Assets $ 16,737     $ 38,676  
Liabilities & Stockholders’ Equity      
Current Liabilities      
Accounts payable $ 6,928     $ 2,932  
Accrued and other liabilities   2,085       2,596  
Line of credit   1,741        
Term loan, net   2,881        
Operating lease liability   57       52  
Total Current Liabilities   13,692       5,580  
Non-current Liabilities      
Line of credit, net         11,444  
Operating lease liability   67       124  
Total Non-current Liabilities   67       11,568  
Total Liabilities   13,759       17,148  
Stockholders’ Equity      
Common Stock, $0.001 par value, 200,000,000 shares authorized, 729,026 & 668,869 shares issued and outstanding as of December 31, 2023, and December 31, 2022, respectively   32       29  
Additional paid-in capital   324,288       320,071  
Accumulated deficit   (313,342 )     (298,572 )
Total Stockholders’ Equity   2,978       21,528  
Total Liabilities and Stockholders’ Equity $ 16,737     $ 38,676  


Better Choice Company Inc.
Non-GAAP Measures

Adjusted EBITDA

We define Adjusted EBITDA as EBITDA further adjusted to eliminate the impact of certain items that we do not consider indicative of our core operations. Adjusted EBITDA is determined by adding the following items to net (loss) income: interest expense, tax expense, depreciation and amortization, share-based compensation, loss on disposal of assets, impairment of goodwill and intangible assets, change in fair value of warrant liabilities, strategic branding initiatives and product launch expenses, co-manufacturing partner transition, and other non-recurring expenses.

We present Adjusted EBITDA as it is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. We believe that the disclosure of Adjusted EBITDA is useful to investors as this non-GAAP measure forms the basis of how our management team reviews and considers our operating results. By disclosing this non-GAAP measure, we believe that we create for investors a greater understanding of and an enhanced level of transparency into the means by which our management team operates our company. We also believe this measure can assist investors in comparing our performance to that of other companies on a consistent basis without regard to certain items that do not directly affect our ongoing operating performance or cash flows.

Adjusted EBITDA does not represent cash flows from operations as defined by GAAP. Adjusted EBITDA has limitations as a financial measure and you should not consider it in isolation, or as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including various cash flow metrics, net (loss) income, gross margin, and our other GAAP results.

The following table presents a reconciliation of net loss, the closest GAAP financial measure, to EBITDA and Adjusted EBITDA for each of the periods indicated (in thousands):

Reconciliation of Net Loss to EBITDA and Adjusted EBITDA
(Dollars in thousands)
  Three Months Ended
December 31,
  Year Ended
December 31,
  2023   2022   2023   2022
Net loss available to common stockholders $ (14,701 )   $ (24,362 )   $ (22,770 )   $ (39,316 )
Interest expense, net   433       227       1,353       551  
Income tax expense   2       (22 )     2     (18 )
Depreciation and amortization   417       425       1,678       1,690  
EBITDA   (13,849 ))     (23,732 )     (19,737 )     (37,093 )
Non-cash share-based compensation (a)   157       515       1,775       2,969  
Impairment of goodwill         18,614             18,614  
Impairment of intangible assets   8,532             8,532        
Change in fair value of warrant liabilities   1,575             236        
Loss on disposal of assets   1       3       12       29  
Strategic branding initiatives and product launches (b)   44       (480 )     128       1,046  
Transaction related (c)   137             935        
Other single occurrence expenses (d)   46       264       149       2,654  
Adjusted EBITDA $ (3,359 )   $ (4,819 )   $ (7,973 )   $ (11,781 )
(a) Non-cash expenses related to equity compensation awards. Share-based compensation is an important part of the Company's compensation strategy and without our equity compensation plans, it is probable that salaries and other compensation related costs would be higher.
(b) Single occurrence expenses related to marketing agency and design, strategic re-branding initiatives, Elevate® launch, product innovation and reformulations.
(c) Transaction-related legal fees and professional fees related to single occurrence business matters.
(d) Reflects non-recurring launch expenses related to the Elevate® launch.
(e) Other single occurrence expenses such as legal settlements, employee severance, executive recruitment, transition of our dry kibble co-manufacturing supplier, and other non-recurring fees.

About Better Choice Company Inc.

Better Choice Company Inc. is a pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. We offer a broad portfolio of pet health and wellness products for dogs and cats sold under our Halo brand across multiple forms, including kibble, canned food, freeze-dried raw food and treats, vegan dog food and treats, oral care products, toppers and other chews and supplements. We have a demonstrated, multi-decade track record of success and are well positioned to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. Halo’s core products are made with high-quality, thoughtfully sourced ingredients for natural, science-based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. For more information, please visit

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
Better Choice Company Inc.
Kent Cunningham, CEO

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254

Primary Logo

Source: Better Choice Company Inc.